SUBSTIPHARM — Nifedipine Importer Profile
Pharmaceutical Importer · #14 buyer for Nifedipine · $376.0K import value · 14 shipments · FRANCE · DGFT Verified
SUBSTIPHARM is the #14 importer of Nifedipine from India with $376.0K in import value and 14 verified shipments. SUBSTIPHARM holds a 1.2% market share in Nifedipine imports based in FRANCE. The company sources from 1 verified supplier across 4 formulations shipped to 1 country. Overall, SUBSTIPHARM imports 3 pharmaceutical products worth $7.3M across 3 therapeutic categories.
SUBSTIPHARM — Nifedipine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Nifedipine to SUBSTIPHARM?
Verified from 14 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDREICH LIMITED | $376.0K | 14 | 100.0% |
SUBSTIPHARM sources Nifedipine from 1 verified Indian supplier based on 14 customs records. The primary supplier is MEDREICH LIMITED accounting for 100.0% of imports.
How Does SUBSTIPHARM Compare to Nearest Nifedipine Importers?
Buyers ranked immediately above and below #14 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | BIOTECH LABORATORIES (PTY) LTD | SOUTH AFRICA | $550.1K | 18 | $30.6K |
| 6 | PHARMASCIENCE INC ,- | CANADA | $500.0K | 10 | $50.0K |
| 14 | SUBSTIPHARM ★ | FRANCE | $376.0K | 14 | $26.9K |
| 15 | PHARMANOVA LIMITED | GHANA | $282.8K | 39 | $7.3K |
| 16 | GEORGE STEUART HEALTH PVT LTD., | SRI LANKA | $281.9K | 10 | $28.2K |
SUBSTIPHARM ranks #14 among 666 Nifedipine importers from India. Average shipment value of $26.9K compared to the market average of $18.0K. The closest competitors by value are BIOTECH LABORATORIES (PTY) LTD and PHARMASCIENCE INC ,-.
Where Does SUBSTIPHARM Import Nifedipine To?
Destination countries from 14 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $376.0K | 14 | 100.0% |
SUBSTIPHARM imports Nifedipine to 1 country. The primary destination is FRANCE receiving 100.0% of shipments worth $376.0K.
What Nifedipine Formulations Does SUBSTIPHARM Import?
| Formulation | Value | Shipments |
|---|---|---|
| ATENOLOL 50 MG AND NIFEDIPINE 20MG CAPSU | $147.9K | 8 |
| ATENOLOL 50MG / NIFEDIPINE 20MG CAPSULES | $116.8K | 3 |
| ATENOLOL 50MG/NIFEDIPINE 20MG CAPSULES M | $76.1K | 2 |
| ATENOLOL 50MG AND NIFEDIPINE 20MG CAPSUL | $35.2K | 1 |
SUBSTIPHARM imports 4 distinct Nifedipine formulations from India. The top formulation is ATENOLOL 50 MG AND NIFEDIPINE 20MG CAPSU with 8 shipments worth $147.9K.
Who Are the Top Buyers of Nifedipine from India and How Much Does SUBSTIPHARM Import?
India exported $12.0M worth of Nifedipine through 2,751 shipments from 331 suppliers to 117 countries, serving 666 buyers globally. SUBSTIPHARM imports $376.0K of this total, accounting for 1.2% of India's Nifedipine exports with 14 shipments from FRANCE. This is verified from 14 customs shipment records covering 4 distinct formulations.
What Is the Average Order Value for SUBSTIPHARM's Nifedipine Imports?
SUBSTIPHARM's average Nifedipine order value is $26.9K per consignment, based on 14 shipments totaling $376.0K. SUBSTIPHARM is based in FRANCE and ranks #14 among all Nifedipine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Nifedipine to SUBSTIPHARM?
SUBSTIPHARM sources Nifedipine from 1 verified Indian supplier: MEDREICH LIMITED ($376.0K, 100.0%). This is based on 14 customs records.
How Does SUBSTIPHARM Compare to Other Nifedipine Importers?
SUBSTIPHARM ranks #14 among 666 Nifedipine importers from India with a 1.2% market share. The top 3 importers are ASCEND LABORATORIES,LLC ($2.3M), PHARMACEUTICAL AND CHEMICAL ($1.5M), PHARMACEUTICAL TECHNOLOGY ($1.2M). SUBSTIPHARM processed 14 shipments from FRANCE.
About SUBSTIPHARM
SUBSTIPHARM imports 3 products worth $7.3M. Beyond Nifedipine, top products include Tramadol, Bisacodyl. View the complete SUBSTIPHARM profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nifedipine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nifedipine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SUBSTIPHARM matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SUBSTIPHARM's capped import value divided by total capped export value for Nifedipine across all Indian exporters.
- 5.Verified Records: This page is backed by 14 individual customs records matching SUBSTIPHARM importing Nifedipine, covering 4 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 117+ countries, 666+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nifedipine Import Data for SUBSTIPHARM
Access order-level details, pricing data, supplier connections, and competitive analysis for SUBSTIPHARM's Nifedipine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUBSTIPHARM
Full Company Profile →
3 products · $7.3M total trade · 3 categories
SUBSTIPHARM × Nifedipine
Verified from customs records
Company Overview
Top Products by SUBSTIPHARM
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SUBSTIPHARM.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nifedipine. For current order-level data, contact TransData Nexus.